X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

TTNP

Closed

Titan Pharmaceuticals Inc

5.73
-0.18 (-3.05%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 5.91
Day's Range: 5.61 - 6.14
Send
When Written:
 
0.7902
Titan Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of innovative treatments for serious medical conditions. The company's primary focus is on the development of products for the treatment of opioid addiction and other substance abuse disorders.

Titan Pharmaceuticals Inc's flagship product is Probuphine, a subdermal implant that delivers a continuous dose of buprenorphine, a medication used to treat opioid addiction. The company also has a pipeline of other products in development, including products for the treatment of Parkinson's disease and hypothyroidism.

Titan Pharmaceuticals Inc was founded in 1992 and is headquartered in South San Francisco, California. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol TTNP.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:18.226.93.100
X